0 followers
NRx is a clinical-stage pharmaceutical company that is developing ZYESAMI (aviptadil acetate) for COVID-19 and NRX-101, the first oral therapeutic for the treatment of Acute Suicidal Behavior/Ideation (ASIB) in Bipolar Disorder.
Industries
Headquarters
Stage
Employees
Links
View full screen
Stephen Willard
View all
6 members
9 members
3 members
2 members
Kymera Therapeutics
3 followers
Cartesian Therapeutics
1 follower
Tempus Labs
12 followers
Ultragenyx Pharmaceutical
5 followers
Biogen
92 followers
Explore more companies